For Corporate Purchasing Managers, Technical Directors, and Operations Leaders who need a reproducible, high‑quality animal model to de‑risk pre‑clinical pipelines, Global Technology delivers a factory‑grade EAE model with OEM/ODM design flexibility, ISO‑9001 quality assurance, and high‑speed delivery worldwide.
Get Free Sample & Quote in 24 hMultiple‑sclerosis (MS) remains one of the most challenging neuro‑degenerative disorders, with global expenditures projected to exceed $15 B by 2028. The Experimental Autoimmune Encephalomyelitis (EAE) model is the gold standard for mimicking MS‑related demyelination, immune infiltration, and clinical relapse. Yet, many laboratories still grapple with unreliable supplies, inflated costs, and long lead times—issues that directly erode ROI and delay IND submissions.
Imagine the impact if you could secure a high‑purity, GMP‑certified EAE model at 30 % lower cost, with 10‑day delivery, and full documentation for regulatory review. That’s the competitive edge your team deserves.
See How We Solve It →Leveraging a powerful Chinese supply chain backed by GMP‑certified manufacturers, our team delivers a complete, ready‑to‑use EAE model package that eliminates the five pain points listed above.
| Parameter | Standard Offering | Custom Options |
|---|---|---|
| Species | C57BL/6J mice (8‑10 weeks) | Rats, BALB/c, transgenic lines |
| Antigen | MOG35‑55 (200 µg) | PLP139‑151, MBP, custom peptides |
| Adjuvant | Complete Freund’s Adjuvant (CFA) | Incomplete Freund’s, Titermax, MPLA |
| Dosage Schedule | Day 0 (subcutaneous), Day 2 (pertussis toxin) | Single‑dose, repeat‑dose, delayed‑onset protocols |
| Purity & Endotoxin | ≥ 98 % (HPLC), <0.1 EU/mL | Custom analytical reports |
| Documentation | COA, GMP batch release, CE certificate | Regulatory dossier support, SOPs |
Scenario 1 – Early‑Stage Therapeutic Screening
A biotech startup in Boston reduced its lead‑identification timeline from 90 days to 45 days by sourcing our “ready‑to‑inject” EAE kits, saving $120,000 in labor and animal‑housing costs.
Scenario 2 – Biomarker Validation for FDA Submission
A multinational pharma partner used our GMP‑certified batches to generate reproducible cytokine profiles (IL‑17, IFN‑γ) across three CRO sites, achieving a 95 % inter‑site concordance—critical for a successful IND filing.
Scenario 3 – Custom Strain Development
A university lab required a C57BL/6J‑NOD hybrid for studying peripheral immune tolerance. Our ODM service delivered a fully characterized hybrid line within 6 weeks, enabling a grant‑winning project funded at $2 M.
ETB-receptor-agonist-research-tool Endocrine-research-peptide-standard-service Analgesic-research-chemical CAS-98395-76-7-Nafarelin-Acetate
ISO 9001 |
GMP‑Certified Production |
FDA‑Registered Facility |
CE Mark |
RoHS
Standard batches ship within 10 business days after payment confirmation. Custom OEM projects require 3‑4 weeks, depending on strain and antigen specifications.

Yes. We offer a **risk‑free 2‑week pilot** (up to 5 mice) with no charge for qualified institutional buyers. Shipping is on us.
Absolutely. Every batch includes a **Certificate of Analysis (COA)**, GMP batch release, and a **regulatory dossier** that meets FDA, EMA, and PMDA requirements.
Our kits follow the standardized immunization protocol widely cited in peer‑reviewed literature. We also provide a **custom SOP** if you need adjustments for specific adjuvants or dosing schedules.
A dedicated project manager is assigned to each order. You receive 24/7 email support, plus a quarterly on‑site audit option for large contracts.
Limited‑time offer: Place an order before 31 May 2026 and receive free air‑freight plus a **30‑day money‑back guarantee** if the model does not meet your pre‑defined clinical scoring criteria.
Dr. Maya Singh (University of California, San Diego) – “The **purity** and **reproducibility** saved us 3 months of repeat experiments. Highly recommend for any pre‑clinical pipeline.”
Tomás García (R&D Lead, Biogen) – “Fast shipping and full regulatory package made our IND filing smooth. The **risk‑free sample** convinced our steering committee.”
Laura Kim (Procurement Director, Pfizer) – “Cost‑effective OEM service with **transparent pricing**. We saved over $200k in the first year.”
Dr. Alan Zhou, PhD – Senior Scientist, Global Technology Co., Ltd.
With 15 years of experience in neuro‑immunology research and a track record of delivering GMP‑grade animal models to Fortune 500 pharma, Dr. Zhou leads the **EAE Platform** at Global Technology. He holds an MSc in Immunology (University of Cambridge) and is a regular reviewer for *Journal of Neuroimmunology*.
Global Technology Co., Ltd
No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Contact Page
© 2026 Global Technology Co., Ltd. All rights reserved. Privacy Policy and Terms of Service are available upon request.